scholarly journals Interagency approaches to animal models for acute radiation exposure

Author(s):  
Kasandra S. Hunter ◽  
Lisa S. Carnell ◽  
Andrea L. DiCarlo ◽  
Corey M. Hoffman ◽  
Shannon G. Loelius ◽  
...  
Author(s):  
Nataliya Uzlenkova

The review systematized the current data on new classes of pharmacological compounds and biologically active substances in the field of radiation protection in Ukraine, as well as abroad. Methodological approaches and the importance of using appropriate animal models in the development of new pharmacological drugs for radiation protection are described, specifically in the cases when it is impossible to conduct full clinical trials on patients. Current views on the division of pharmacological agents into radioprotectors, radiomitigators, and therapeutic radiation protection agents are examined. The changes in the hematopoietic tissue, gastrointestinal tract and neurovascular system that occur after acute radiation exposure are also described. Particular attention is paid to pharmacological agents that can protect against acute exposure to ionizing radiation by limiting the risk of radiation mortality from the hematological and gastrointestinal forms of radiation syndrome. Results of the effectiveness of tolerant antioxidants with a wide spectrum of biological activity as promising agents for the prevention of acute and delayed radiation-induced pathology, in particular, in lung tissue, are presented. Possible molecular mechanisms of the radioprotective effect of pharmacological compounds on experimental models of total and local radiation exposure are discussed. The effectiveness of the therapeutic use of growth factors and recombinant cytokines in acute bone marrow suppression аfter accidental radiation exposure is shown. The possibilities of cell therapy with myeloid progenitor cells mobilized by tocopherol succinate hematopoietic/progenitor cells and bone marrow mesenchymal stromal cells in acute radiation injuries are shown. Special attention is paid to the importance of improving such methodological approaches and regulatory requirements when introducing into practice new radiation protection facilities in Ukraine. Key words: radiation protection, ionizing radiation, pharmacological agents, acute radiation syndrome. For citation: Uzlenkova NE. New pharmacological means of radiation protection (literature review). Journal of the National Academy of Medical Sciences of Ukraine. 2019;25(3) :268–77


2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Steven J. Miller ◽  
Supriya Chittajallu ◽  
Carol Sampson ◽  
Alexa Fisher ◽  
Joseph L. Unthank ◽  
...  

2019 ◽  
Vol 90 (11) ◽  
pp. 966-977
Author(s):  
Rebecca S. Blue ◽  
Jeffery C. Chancellor ◽  
Rahul Suresh ◽  
Lisa S. Carnell ◽  
David P. Reyes ◽  
...  

INTRODUCTION: Analysis of historical solar particle events (SPEs) provides context for some understanding of acute radiation exposure risk to astronauts who will travel outside of low-Earth orbit. Predicted levels of radiation exposures to exploration crewmembers could produce some health impacts, including nausea, emesis, and fatigue, though more severe clinical manifestations are unlikely. Using current models of anticipated physiological sequelae, we evaluated the clinical challenges of managing radiation-related clinical concerns during exploration spaceflight.METHODS: A literature review was conducted to identify terrestrial management standards for radiation-induced illnesses, focusing on prodromal symptom treatment. Terrestrial management was compared to current spaceflight medical capabilities to identify gaps and highlight challenges involved in expanding capabilities for future exploration spaceflight.RESULTS: Current spaceflight medical resources, such as those found on the International Space Station, may be sufficient to manage some aspects of radiation-induced illness, although effective treatment of all potential manifestations would require substantial expansion of capabilities. Terrestrial adjunctive therapies or more experimental treatments are unavailable in current spaceflight medical capabilities but may have a role in future management of acute radiation exposure.DISCUSSION: Expanded medical capabilities for managing radiation-induced illnesses could be included onboard future exploration vehicles. However, this would require substantial research, time, and funding to reach flight readiness, and vehicle limitations may restrict such capabilities for exploration missions. The benefits of including expanded capabilities should be weighed against the likelihood of significant radiation exposure and extensive mission design constraints.Blue RS, Chancellor JC, Suresh R, Carnell LS, Reyes DP, Nowadly CD, Antonsen EL. Challenges in clinical management of radiation-induced illnesses during exploration spaceflight. Aerosp Med Hum Perform. 2019; 90(11):966–977.


Epidemiology ◽  
2009 ◽  
Vol 20 ◽  
pp. S37
Author(s):  
Erin Semmens ◽  
Jean McDougall ◽  
Eric Grant ◽  
Nobuo Nishi ◽  
Kazunori Kodama ◽  
...  

2021 ◽  
Vol 195 (4) ◽  
Author(s):  
Andrea M. Patterson ◽  
Rajendran Sellamuthu ◽  
P. Artur Plett ◽  
Carol H. Sampson ◽  
Hui Lin Chua ◽  
...  

2014 ◽  
Vol 50 ◽  
pp. S139 ◽  
Author(s):  
Y. Shimada ◽  
M. Nishimura ◽  
T. Imaoka ◽  
K. Daino ◽  
Y. Yamada ◽  
...  

2018 ◽  
Vol 23 (04) ◽  
pp. 1 ◽  
Author(s):  
Pouya Jelvehgaran ◽  
Daniel Martijn de Bruin ◽  
F. Javier Salguero ◽  
Gerben Roelof Borst ◽  
Ji-Ying Song ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document